How GH Secretagogues Reverse Age-Related GH Decline: Restoring the Aging GH/IGF-I Axis

GH secretagogues progressively reversed age-related GH/IGF-I decline in rats through restoring hypothalamic-pituitary sensitivity, with combined GHRP + GHRH showing the most effective restoration in aged animals.

Frutos, Miriam García-San et al.·American journal of physiology. Endocrinology and metabolism·2007·Moderate EvidenceAnimal StudyAnimal Study
RPEP-01227Animal StudyModerate Evidence2007RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

GH secretagogues reversed age-related GH/IGF-I axis decline in aged rats by restoring hypothalamic GHRH sensitivity and pituitary responsiveness, with combined GHRP + GHRH achieving the most complete axis restoration for anti-aging neuroendocrine therapy.

Key Numbers

How They Did This

animal-study study on ghrp, hormone-optimization.

Why This Research Matters

Relevant for ghrp, hormone-optimization, anti-aging.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding GH secretagogues reversed age-related GH/IGF-I axis decline in aged rats by restoring hypothalamic GHRH sensitivity and pituitary responsiveness, with
Evidence Grade:
moderate evidence.
Study Age:
Published in 2007.
Original Title:
Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.
Published In:
American journal of physiology. Endocrinology and metabolism, 293(5), E1140-52 (2007)
Database ID:
RPEP-01227

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

How GH Secretagogues Reverse Age-Related GH Decline: Restoring the Aging GH/IGF-I Axis

What was found?

GH secretagogues progressively reversed age-related GH/IGF-I decline in rats through restoring hypothalamic-pituitary sensitivity, with combined GHRP + GHRH showing the most effective restoration in aged animals.

Read More on RethinkPeptides

Cite This Study

RPEP-01227·https://rethinkpeptides.com/research/RPEP-01227

APA

Frutos, Miriam García-San; Cacicedo, Lucinda; Fernández, Carolina; Vicent, David; Velasco, Beatriz; Zapatero, Helena; Sánchez-Franco, Franco. (2007). Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.. American journal of physiology. Endocrinology and metabolism, 293(5), E1140-52.

MLA

Frutos, Miriam García-San, et al. "Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.." American journal of physiology. Endocrinology and metabolism, 2007.

RethinkPeptides

RethinkPeptides Research Database. "Insights into a role of GH secretagogues in reversing the ag..." RPEP-01227. Retrieved from https://rethinkpeptides.com/research/frutos-2007-insights-into-a-role

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.